Private Equity: Erst Opernabende, dann Anwälte: Der Machtkampf um die Med-Tech-Firma Brainlab eskaliert
Stefan Vilsmeier und der Finanzinvestor EMH wollten Brainlab an die Börse bringen. Jetzt fordert EMH Schadenersatz vom Gründer. Der will den größten Investor aus dem Aufsichtsrat werfen.
Private equity firm EMH Partners has launched a legal battle with Brainlab, a pioneering Munich-based Med-Tech company. The dispute erupted after EMH accused founder Stefan Vilsmeier of prioritizing his own interests over those of the company. Brainlab contends that it no longer trusts Kuss and that he is no longer a viable partner. The two companies are set to face shareholders in Munich, marking a dramatic climax to a story that could have made German history.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
